Recordati Group
Clinical trials sponsored by Recordati Group, explained in plain language.
-
New hope for kids with rare hormone disorder
Disease control Recruiting nowThis study is testing a drug called osilodrostat in children and teenagers (ages 2 to 18) with Cushing's syndrome, a rare condition caused by too much of the stress hormone cortisol. The main goal is to understand how the child's body processes the drug and to see if it safely lo…
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Global effort launches to map rare blood Disorder's Real-World impact
Knowledge-focused Recruiting nowThis study is creating a long-term registry to collect real-world information from 400 adults diagnosed with Cold Agglutinin Disease (CAD) or Cold Agglutinin Syndrome (CAS). The goal is to better understand how the disease progresses, what treatments patients receive, and how it …
Sponsor: RECORDATI GROUP • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC